首页> 外文会议>Advanced biomedical and clinical diagnostic systems X >Plasmonic Coupling Interference: A New Approach for Cancer Diagnostics using SERS Detection
【24h】

Plasmonic Coupling Interference: A New Approach for Cancer Diagnostics using SERS Detection

机译:等离子体耦合干扰:一种使用SERS检测进行癌症诊断的新方法

获取原文
获取原文并翻译 | 示例

摘要

We have developed a novel label-free approach referred to as plasmonic coupling interference (PCI) nanoprobes for nucleic acid detection using surface-enhanced Raman scattering (SERS). To induce a strong plasmonic coupling effect and SERS signal, a nano-network of silver nanoparticles having the Raman label located between adjacent nanoparticles is assembled by Raman-labeled nucleic acid duplexes. The PCI method then utilizes specific nucleic acid sequences of interest as competitor elements of the Raman-labeled DNA probes to interfere the formation of the nucleic acid-cross-linked nano-networks in a competitive binding process, resulting in a reduced SERS signal. We illustrate the potential of the PCI technique for biomedical applications by detecting single-nucleotide polymorphism (SNP) and microRNA sequences involved in breast cancers. The results of this study could lead to the development of nucleic acid diagnostic tools for biomedical diagnostics and biosensing applications using SERS detection.
机译:我们已经开发了一种称为表面等离子体拉曼散射(SERS)的用于核酸检测的称为等离子体耦合干扰(PCI)纳米探针的新型无标记方法。为了诱导强烈的等离子体耦合效应和SERS信号,通过拉曼标记的核酸双链体组装具有位于相邻纳米颗粒之间的拉曼标记的银纳米颗粒的纳米网络。然后,PCI方法利用感兴趣的特定核酸序列作为拉曼标记的DNA探针的竞争元件,以竞争性结合过程干扰核酸交联的纳米网络的形成,从而降低SERS信号。我们通过检测乳腺癌中涉及的单核苷酸多态性(SNP)和microRNA序列来说明PCI技术在生物医学应用中的潜力。这项研究的结果可能会导致开发用于SERS检测的生物医学诊断和生物传感应用的核酸诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号